flexiblefullpage
billboard
interstitial1
catfish1
Currently Reading

Life sciences construction market is poised for a comeback: JLL

Laboratories

Life sciences construction market is poised for a comeback: JLL

After reset period, the resilient life sciences industry offers opportunities and bright spots for both occupiers and owners


By JLL | September 20, 2023
Image by OsloMetX from Pixabay
Image by OsloMetX from Pixabay

The life sciences commercial real estate market has undergone a reset this year but is well positioned to be the comeback kid as capital sources grow more confident and green shoots emerge, according to JLL’s 2023 Life Sciences Industry and Real Estate Perspective. The report explores the state of the industry and identifies trends – and opportunities – for current and future lab space demand, along with the annual ranking of the top innovation communities. Additionally, JLL Research has added two new cluster rankings that reveal the five top markets for both medical technology (medtech) and biomanufacturing.

Though current industry fundaments have slowed, demand is well positioned to rebound. The top 20 venture capital (VC) firms focused on life sciences are waiting to deploy record amounts of capital. They’ve raised over $22 billion collectively since 2021 that will soon find its way into growing startups. With ample funds to close deals, the rest of 2023 will likely see mega M&A deals for companies with top-notch science deep into their clinical trials.

“The relationship between funding rounds and startup expansion are symbiotic, driving growth throughout the biotech sector, and, while the public markets have slightly cooled off, private capital remains hopeful with record dry powder from top VCs focused on life sciences,” said Travis McCready, Head of Life Sciences, Americas Markets, JLL.

The supply landscape shifted dramatically over the past 18 months, proving how sensitive the biotech sector is to microeconomic forces. At the end of 2021, demand across the top eight markets in the U.S. was more than 25 million square feet. By mid-2023, that had fallen to just over 10 million square feet.

Still, opportunities exist for tenants and landlords. A bright spot is small biotech occupiers that have a critical need for bench space. Throughout 2023, they have been the largest seeker of new space, as opposed to mid- to late-stage companies that can pause expansion plans and operate within their current space. Sub-30,000 square foot tenants accounted for 82% of deals signed in the first half of 2023, up from the previous average of 65%.

“Established pharmaceutical companies and biotechs have the chance to strategically select long-term markets for R&D growth,” said Kevin Wayer, President, Life Sciences, Work Dynamics Division, JLL. “It’s the perfect opportunity for larger companies to analyze their real estate portfolios and facilities and make informed location choices, as well as for growing companies and startups seeking to scale. It marks a new era of strategic decision-making in the life sciences industry.”

The top life sciences innovation communities

JLL Research looked at the three main components of what comprises a successful life sciences ecosystem, which are access to talent, funding that leads to commercialization and real estate infrastructure that supports current activities and further growth.

Once again, Greater Boston (1), the San Francisco Bay Area (2) and San Diego (3) reign supreme as the top three markets for life sciences commercial real estate in the U.S. It’s taken decades for these clusters to mature and evolve. Greater DC and Baltimore, Raleigh-Durham, New Jersey, New York City, Boulder and the Northwest Corridor, Philadelphia and Seattle round out the top 10, respectively.

“The elements that are mission critical for young startups to grow are numerous, and, while the top 10 markets provide what is necessary for the discovery and clinical stages and house the highest concentration of VCs with deep industry knowledge, new markets like Los Angeles, Chicago and Houston are showing signs of significant growth and potential,” added Maddie Holmes, Senior Research Analyst, Life Sciences Industry Insight and Advisory, JLL. “These emerging clusters are attracting investments from universities, institutions, governments and industry players who recognize the importance of fostering breakthrough scientific developments.”

New rankings: Medtech and biomanufacturing markets

The life sciences industry is more than the development of new therapeutics; it involves other life-impacting scientific endeavors such as medical devices and technologies and biomanufacturing, which are key drivers of the overall industry’s evolution. The long-term growth prospects for both medtech and biomanufacturing are exceptional, and, given the significant capital investments and the pivotal role of manufacturing operations in a company's success, choosing locations and sites with long-term value and optimal deployment is imperative.

Through complex analysis focused on variables specific to medtech and biomanufacturing, JLL Research uncovered the top five markets that show strength in these specific subsectors. Skilled talent and its growing demand, innovation measured by clinical trials and venture capital funding, and industry performance and concentration were among the evaluated factors.

For MedTech, Orange County, Calif., is the top-ranked market due to its presence of renowned academic and research institutions, support of the local government and industry associations and strong VC presence. Minneapolis-Saint Paul (2), the San Francisco Bay Area (3), Greater Boston (4) and Salt Lake City (5) comprise the remaining top clusters.

When it comes to the top biomanufacturing market, look no further than established juggernaut Raleigh-Durham. The area is uniquely positioned due to the history of large-scale biomanufacturing in and around Research Triangle Park and the outlying counties, large talent pool and three tier-one universities. Philadelphia (2), New Jersey (3), Greater Boston (4) and the San Francisco Bay Area (5) make up the top five.

“Medical device and testing companies represent a huge swath of the life sciences landscape in the U.S., and biomanufacturing is a critical piece of a therapeutic company’s lifecycle” said Mark Bruso, Research Director, New England and U.S. Life Sciences, JLL. “Markets that specialize in these fields and have high concentrations of talent are not necessarily the same as traditional R&D hubs, so it was important for us to shine a light on the strongest medtech and biomanufacturing hubs in the country for the first time.”

JLL's vision is to reimagine the world of real estate, creating, finding, locating and operating safe and amazing spaces. JLL’s Life Sciences team of 3,000+ experienced professionals are a safe pair of hands to help biotechnology, pharmaceutical, medical devices organizations, investors and developers achieve their ambitions. JLL brings deep understanding of location analytics, project management, research advisory, financial incentives, transaction management, capital markets, real estate strategy and technology, facilities management, regulatory compliance and quality, and more. Our solutions help fuel innovation, enhance efficiency, improve financial performance and attract and retain top talent. Our team is trained and certified to operate within office and critical, regulated environments of lab and manufacturing space. To learn more, visit us.jll.com/lifesciences.

Related Stories

Laboratories | May 24, 2024

The Department of Energy breaks ground on the Princeton Plasma Innovation Center

In Princeton, N.J., the U.S. Department of Energy’s Princeton Plasma Physics Laboratory (PPPL) has broken ground on the Princeton Plasma Innovation Center (PPIC), a state-of-the-art office and laboratory building. Designed and constructed by SmithGroup, the $109.7 million facility will provide space for research supporting PPPL’s expanded mission into microelectronics, quantum sensors and devices, and sustainability sciences. 

Laboratories | Apr 22, 2024

Why lab designers should aim to ‘speak the language’ of scientists

Learning more about the scientific work being done in the lab gives designers of those spaces an edge, according to Adrian Walters, AIA, LEED AP BD+C, Principal and Director of SMMA's Science & Technology team.

Laboratories | Apr 15, 2024

HGA unveils plans to transform an abandoned rock quarry into a new research and innovation campus

In the coastal town of Manchester-by-the-Sea, Mass., an abandoned rock quarry will be transformed into a new research and innovation campus designed by HGA. The campus will reuse and upcycle the granite left onsite. The project for Cell Signaling Technology (CST), a life sciences technology company, will turn an environmentally depleted site into a net-zero laboratory campus, with building electrification and onsite renewables.

Laboratories | Apr 12, 2024

Life science construction completions will peak this year, then drop off substantially

There will be a record amount of construction completions in the U.S. life science market in 2024, followed by a dramatic drop in 2025, according to CBRE. In 2024, 21.3 million sf of life science space will be completed in the 13 largest U.S. markets. That’s up from 13.9 million sf last year and 5.6 million sf in 2022.

Sustainability | Mar 21, 2024

World’s first TRUE-certified building project completed in California

GENESIS Marina, an expansive laboratory and office campus in Brisbane, Calif., is the world’s first Total Resource Use and Efficiency (TRUE)-certified construction endeavor. The certification recognizes projects that achieve outstanding levels of resource efficiency through waste reduction, reuse, and recycling practices.

Adaptive Reuse | Mar 7, 2024

3 key considerations when converting a warehouse to a laboratory

Does your warehouse facility fit the profile for a successful laboratory conversion that can demand higher rents and lower vacancy rates? Here are three important considerations to factor before proceeding. 

University Buildings | Feb 21, 2024

University design to help meet the demand for health professionals

Virginia Commonwealth University is a Page client, and the Dean of the College of Health Professions took time to talk about a pressing healthcare industry need that schools—and architects—can help address.

Urban Planning | Feb 5, 2024

Lessons learned from 70 years of building cities

As Sasaki looks back on 70 years of practice, we’re also looking to the future of cities. While we can’t predict what will be, we do know the needs of cities are as diverse as their scale, climate, economy, governance, and culture.

Laboratories | Feb 5, 2024

DOE selects design-build team for laboratory focused on clean energy innovation

JE Dunn Construction and SmithGroup will construct the 127,000-sf Energy Materials and Processing at Scale (EMAPS) clean energy laboratory in Colorado to create a direct path from lab-scale innovations to pilot-scale production.

Laboratories | Jan 25, 2024

Tactical issues for renovating university research buildings

Matthew Plecity, AIA, ASLA, Principal, GBBN, highlights the connection between the built environment and laboratory research, and weighs the benefits of renovation vs. new construction.

boombox1
boombox2
native1

More In Category

Laboratories

The Department of Energy breaks ground on the Princeton Plasma Innovation Center

In Princeton, N.J., the U.S. Department of Energy’s Princeton Plasma Physics Laboratory (PPPL) has broken ground on the Princeton Plasma Innovation Center (PPIC), a state-of-the-art office and laboratory building. Designed and constructed by SmithGroup, the $109.7 million facility will provide space for research supporting PPPL’s expanded mission into microelectronics, quantum sensors and devices, and sustainability sciences. 



Laboratories

HGA unveils plans to transform an abandoned rock quarry into a new research and innovation campus

In the coastal town of Manchester-by-the-Sea, Mass., an abandoned rock quarry will be transformed into a new research and innovation campus designed by HGA. The campus will reuse and upcycle the granite left onsite. The project for Cell Signaling Technology (CST), a life sciences technology company, will turn an environmentally depleted site into a net-zero laboratory campus, with building electrification and onsite renewables.


halfpage1

Most Popular Content

  1. 2021 Giants 400 Report
  2. Top 150 Architecture Firms for 2019
  3. 13 projects that represent the future of affordable housing
  4. Sagrada Familia completion date pushed back due to coronavirus
  5. Top 160 Architecture Firms 2021